AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
| Q1 2023 | $115 | -91.4% | 396 | -86.7% | 0.00% | – |
| Q4 2022 | $1,335 | -99.8% | 2,968 | +88.4% | 0.00% | – |
| Q3 2022 | $828,000 | -68.9% | 1,575 | -70.1% | 0.00% | – |
| Q2 2022 | $2,661,000 | -67.7% | 5,269 | +47.2% | 0.00% | – |
| Q1 2022 | $8,234,000 | -84.5% | 3,580 | -67.9% | 0.00% | – |
| Q4 2021 | $53,005,000 | -38.0% | 11,159 | +3.7% | 0.00% | – |
| Q3 2021 | $85,510,000 | +161.1% | 10,756 | +128.6% | 0.00% | – |
| Q2 2021 | $32,747,000 | -40.6% | 4,705 | -32.4% | 0.00% | – |
| Q1 2021 | $55,123,000 | -20.5% | 6,960 | -21.0% | 0.00% | – |
| Q4 2020 | $69,335,000 | -1.7% | 8,810 | -11.4% | 0.00% | – |
| Q3 2020 | $70,510,000 | +294.4% | 9,945 | +414.5% | 0.00% | – |
| Q2 2020 | $17,880,000 | -52.5% | 1,933 | -76.1% | 0.00% | – |
| Q1 2020 | $37,620,000 | +52.7% | 8,073 | +150.4% | 0.00% | – |
| Q4 2019 | $24,631,000 | -7.2% | 3,224 | -6.6% | 0.00% | – |
| Q3 2019 | $26,554,000 | +77.9% | 3,453 | +58.5% | 0.00% | – |
| Q2 2019 | $14,926,000 | -54.0% | 2,179 | -46.0% | 0.00% | – |
| Q1 2019 | $32,458,000 | +536.3% | 4,032 | +656.5% | 0.00% | – |
| Q3 2018 | $5,101,000 | -9.5% | 533 | 0.0% | 0.00% | – |
| Q2 2018 | $5,639,000 | – | 533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |